News
The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...
The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.
The US Food and Drug Administration changes Covid-19 vaccine approval process. Access to seasonal boosters is restricted for ...
JPMorgan analyst Eric Joseph reaffirmed an Underweight rating for Novavax Inc. (NASDAQ:NVAX) with a price target of $7. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results